Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis.

Alessio RizzoManuela RaccaDomenico Albano Francesco DondiFrancesco BertagnaSalvatore AnnunziataGiorgio Treglia

Published in: Pharmaceuticals (Basel, Switzerland) (2022)

The quantitative data provided demonstrate the high DR of PET/CT or PET/MRI with PSMA-targeting radiopharmaceuticals for HCC lesion detection. However, more studies are needed to confirm the promising role of PSMA-targeted PET in HCC.

Keyphrases

pet ct
positron emission tomography
cancer therapy
pet imaging
computed tomography
magnetic resonance imaging
drug delivery
contrast enhanced
high resolution
label free
editorial comment
real time pcr
sensitive detection